Testing effectiveness (Phase 2)Study completedNCT01563445
What this trial is testing
Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage
Who this might be right for
Acquired Bleeding DisorderIntracerebral Haemorrhage
Novo Nordisk A/S 40